Press release
Global Artificial Kidney Market to reach USD 6.09 billion by 2032 at a CAGR of 12.80% by 2032, Evaluates DelveInsight
DelveInsight's "Artificial Kidney Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Artificial Kidney companies actively working in the market.
To know more about why North America is leading the market growth in the Artificial Kidney market, get a snapshot of the report Artificial Kidney Market Trends
https://www.delveinsight.com/sample-request/artificial-kidney-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Artificial Kidney Overview
An artificial kidney is a medical device designed to perform the vital functions of a natural kidney, primarily filtering waste, toxins, and excess fluids from the blood. It is used for patients with kidney failure or severe kidney dysfunction. Artificial kidneys can be external, like hemodialysis machines, or implantable, which aim to mimic natural kidney functions continuously. These devices help maintain electrolyte balance, remove impurities, and support overall metabolic stability, offering a potential alternative to dialysis and kidney transplantation.
DelveInsight Analysis: The artificial kidney market size was valued at USD 2.33 billion in 2024 and is anticipated to grow at a CAGR of 12.80% from 2025 to 2032, reaching approximately USD 6.09 billion by 2032.
Artificial Kidney Market Insights
Geographically, North America is projected to lead the global artificial kidney market in 2024. This dominance is primarily driven by the growing prevalence of chronic kidney diseases (CKD), including kidney failure and end-stage renal disease (ESRD). Technological advancements such as the introduction of wearable artificial kidneys and compact dialysis devices are further fueling market growth. Moreover, the rising preference for home-based dialysis treatments and the presence of a robust healthcare infrastructure are enhancing market expansion across the region. Together, these factors firmly position North America as the leading market for artificial kidneys.
To read more about the latest highlights related to Artificial Kidney, get a snapshot of the key highlights entailed in the Artificial Kidney Insights
https://www.delveinsight.com/report-store/artificial-kidney-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Recent Developments in the Artificial Kidney Market Report
• In September 2023, Quanta Dialysis Technologies® announced that it submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for an indication expansion of the QuantaTM Dialysis System. This compact and user-friendly hemodialysis device is approved for use in chronic and acute care settings. The new submission seeks to expand its use to include self-care, at-home hemodialysis, offering patients greater flexibility and independence in managing their condition.
• In August 2023, Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, announced that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Versi®HD with GuideMe Software. This new self-guided interface is a complete redesign of the company's VersiHD chronic home hemodialysis (HHD) system.
• In April 2023, Medtronic and DaVita Inc. announced the launch of Mozarc Medical, an independent company dedicated to reshaping kidney health and advancing patient-centered technology solutions. The creation of Mozarc Medical aimed to accelerate innovation in kidney care and deliver transformative solutions that enhance the quality of life for patients with renal diseases. This strategic collaboration underscores both companies' commitment to advancing kidney health through cutting-edge technologies.
• Thus, owing to such developments in the market, rapid growth will be observed in the Artificial Kidney market during the forecast period
Key Players in the Artificial Kidney Market
Some of the key market players operating in the Artificial Kidney market include- Baxter, Fresenius Medical Care AG, B. Braun Melsungen AG, Asahi Kasei Corporation, Nipro Corporation, Nikkiso Co., Ltd., NxStage Medical, Inc., Medtronic, DaVita Inc., SB-KAWASUMI LABORATORIES, INC., Cantel Medical, Rockwell Medical, Inc., BD, Dialife SA, Trivitron Healthcare, TORAY MEDICAL CO., LTD., Lepu Medical Technology (Beijing) Co., Ltd., BenQ Dialysis Technology Corp., Quanta Dialysis Technologies Inc., Nextkidney B.V., and others.
Which MedTech key players in the Artificial Kidney market are set to emerge as the trendsetter explore @ Key Artificial Kidney Companies
https://www.delveinsight.com/sample-request/artificial-kidney-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Analysis on the Artificial Kidney Market Landscape
In addition, advancements in product development by key industry players are further propelling growth in this segment. For instance, in March 2021, Baxter International obtained U.S. FDA approval for its next-generation Artificial Kidney 98 (AK 98) dialysis machine. This portable and user-friendly device includes encrypted two-way connectivity, allowing direct integration with electronic medical records (EMR) to streamline workflows and enhance data management for healthcare professionals.
Such innovations highlight the industry's continued focus on improving the efficiency, accessibility, and quality of dialysis care, thereby driving the expansion of the artificial kidney market.
Scope of the Artificial Kidney Market Report
• Coverage: Global
• Study Period: 2022-2032
• Artificial Kidney Market Segmentation By Product: Instruments and Consumables
• Artificial Kidney Market Segmentation By End-User: Hospitals, Dialysis Centers, and Others
• Artificial Kidney Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Artificial Kidney Companies: Baxter, Fresenius Medical Care AG, B. Braun Melsungen AG, Asahi Kasei Corporation, Nipro Corporation, Nikkiso Co., Ltd., NxStage Medical, Inc., Medtronic, DaVita Inc., SB-KAWASUMI LABORATORIES, INC., Cantel Medical, Rockwell Medical, Inc., BD, Dialife SA, Trivitron Healthcare, TORAY MEDICAL CO., LTD., Lepu Medical Technology (Beijing) Co., Ltd., BenQ Dialysis Technology Corp., Quanta Dialysis Technologies Inc., Nextkidney B.V., and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Interested in knowing how the Artificial Kidney market will grow by 2032? Click to get a snapshot of the Artificial Kidney Market Analysis
https://www.delveinsight.com/sample-request/artificial-kidney-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Artificial Kidney Market to reach USD 6.09 billion by 2032 at a CAGR of 12.80% by 2032, Evaluates DelveInsight here
News-ID: 4259452 • Views: …
More Releases from DelveInsight Business Research
Familial Chylomicronemia Syndrome Market to Expand Significantly by 2034, States …
DelveInsight's "Familial Chylomicronemia Syndrome Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Familial Chylomicronemia Syndrome, historical and forecasted epidemiology as well as the Familial Chylomicronemia Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Familial Chylomicronemia Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Familial Chylomicronemia Syndrome…
Generalized Anxiety Disorder Pipeline 2025: Therapies, MOA Insights, and Key Cli …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Generalized Anxiety Disorder pipeline constitutes 12+ key companies continuously working towards developing 15+ Generalized Anxiety Disorder treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Generalized Anxiety Disorder Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Generalized Anxiety…
Primary Mitochondrial Myopathies Pipeline 2025: MOA, ROA, FDA-Approved Drugs, an …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Primary Mitochondrial Myopathies pipeline constitutes 4+ key companies continuously working towards developing 4+ Primary Mitochondrial Myopathies treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Primary Mitochondrial Myopathies Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Primary Mitochondrial…
Chlamydia Infections Pipeline 2025: Therapies Under Investigation, Clinical Tria …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Chlamydia Infections pipeline constitutes 5+ key companies continuously working towards developing 5+ Chlamydia Infections treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Chlamydia Infections Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also…
More Releases for Artificial
Artificial Intelligence or Artificial Soul by Denise White
Author Denise White exposes the subtle societal forces shaping young minds and offers profound wisdom to help children develop resilience against artificial influences.
As artificial intelligence continues to permeate every aspect of modern life, from self-driving cars to virtual assistants, a critical question arises: Are we sacrificing our authenticity and human essence for the sake of technological advancement? In her latest book, Guarding the Child's Imagination , author Denise White sheds…
Artificial Neural Network Software Market: Advancements in Artificial Neural Net …
The Report on "Artificial Neural Network Software Market" provides Key Benefits, Market Overview, Regional Analysis, Market Segmentation, Future Trends Upto 2030 by Infinitybusinessinsights.com. The report will assist reader with better understanding and decision making.
Market Growth of Artificial Neural Network Software Market: The artificial neural network software market is experiencing robust growth as organizations across various industries increasingly leverage AI-driven solutions to enhance decision-making, automate processes, and gain actionable insights from…
Global Artificial Intelligence Market, Global Artificial Intelligence Industry, …
Major players in the artificial intelligence market are Google, IBM, Baidu, Microsoft, Apple Inc., Ipsoft, NVIDIA Corporation, Samsung Electronics Co.Ltd, and Micro Strategy Inc.
The Global Artificial Intelligence Market is expected to grow from USD 28.42 billion in 2019 to USD 40.74 billion in 2020 at a compound annual growth rate (CAGR) of 43.39%. The growth is mainly due to the COVID-19 health emergency across the globe that has led to…
Artificial Iris Market - Industry Analysis, Size, Share, Growth, Trends, and For …
The global Artificial Iris Market is anticipated to gain the market worth of US$ 16.28 million by 2025, expanding at a CAGR of 6.39% during the forecast period 2019-2025. The natural pupil controls the amount of light that enters the eye and people with pupil or iris abnormalities may experience glare or haloes in sunlight or bright artificial light. Patients may also feel self-conscious about the appearance of their eyes…
Global Artificial Organs Market Facts, Figures and Analytical Insights, 2018 to …
Artificial Organs Market Introduction
Artificial organ is an engineered device or tissue that is implanted into the human body. These artificial organs replace a natural organ in order to duplicate a specific function so that the patient can return to a normal life. It is a medical device with biochemical or mechanical function such as lung, heart, liver, kidney, or neurosensory organs.
Artificial organs are surgically implanted or are extra…
Artificial Kidney Market Report 2018: Segmentation by Type (Wearable Artificial …
Global Artificial Kidney market research report provides company profile for Medtronic, DaVita, Merit Medical Systems, NIPRO Medical Corporation, Nikkiso, B. Braun Melsungen AG, Kawasumi Laboratories, Fresenius, Baxter, Asahi Kasei Medical, Xcorporeal and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for…
